Outcomes4Me: AI-Driven Cancer Care Company Acquires Geno.Me And Realyze Intelligence To Expand Clinical Trial Access - Pulse 2.0
8/10Outcomes4Me, an AI-driven cancer care company, announced on May 24, 2026, the acquisition of Geno.Me and Realyze Intelligence to enhance access to clinical trials. This strategic move aims to expand treatment options and personalize oncology care for cancer patients.
